Recent sequencing studies have identified significant alterations in NRAS, BRAF, NF1, KIT, SF3B1, TP53, and SPRED1, informing potential targeted therapeutic strategies for MM (14–16, 160, 161). The gene discussed is KIT; the disease is Miyoshi myopathy.